24小时热门版块排行榜

返回列表

nyl8791

金虫 (小有名气)

应助: 0 (幼儿园)
金币: 885
红花: 1
帖子: 110
在线: 61.2小时
虫号: 1057033
注册: 2010-07-13
性别: GG
专业: 天然药物化学

[求助] 《结构化学》杂志参考文献修改求助

《结构化学》杂志参考文献修改求助，主编说格式不对，我已经校对过了，但没发现问题，高手可以帮我看下吗？谢谢！
Frías-González, S. E.; Angeles-Anguiano, E.; Mendoza-Herrera, A.; Escutia-Calzada, D.; Ordaz-Pichardo, C. Cytotoxic, pro-apoptotic, pro-oxidant, and non-genotoxic activities of a novel copper(II) complex against human cervical cancer. Toxicology. 2013, 314, 155–165.
Florea, A. M.; Büsselberg, D. Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects. Cancers. 2011, 3, 1351–1371.
Gielen, M.; Tiekink (Eds.), E. R. T. Metallotherapeutic Drugs and Metal-based Diagnostic Agents: The Use of Metals in Medicine. New York: Wiley, 2005, P 1–17.
Devereux, M.; O’Shea, D.; O’Connor, M.; Grehan, H. Synthesis, catalase, superoxide dismutase and antitumour activities of copper(II) carboxylate complexes incorporating benzimidazole, 1,10-phenanthroline and bipyridine ligands: X-ray crystal structures of [Cu(BZA)2(bipy)(H2O)], [Cu(SalH)2(BZDH)2] and [Cu(CH3COO)2(5,6-DMBZDH)2] (SalH2 = salicylic acid; BZAH = benzoic acid; BZDH = benzimidazole and 5,6-DMBZDH = 5,6-dimethylbenzimidazole). Polyhedron. 2007, 26, 4073–4084.
McCann, M.; Coyle, B.; McKay, S.; McCormack, P.; Kavanagh, K.; Devereux, M.; McKee, V.; Kinsela, P.; Connor, R. O.; Clynes, M. Synthesis and X-ray crystal structure of [Ag(phendio)2]ClO4 (phendio = 1,10-phenanthroline-5,6-dione) and its effects on fungal and mammalian cells. Biometals. 2004, 17, 635–654.
Huang, R. L.; Wallqvist, A.; Covell, D. G. Anticancer metal compounds in NCI's tumor-screening database: putative mode of action. Biochemical Pharmacology. 2005, 69, 1009–1039.
Wu, H. L.; Yuan, J. K.; Bai, Y.; Wang, H.; Pan, G. L.; Kong, J. A seven-coordinated manganese(II) complex with V-shaped ligand bis(N-benzylbenzimidazol-2-ylmethyl)benzylamine: Synthesis, structure, DNA-binding properties and antioxidant activities. J. Photoch. Photobio. B. 2012, 116, 13–21.
Wu, H. L.; Yuan, J. K.; Pan, G. L. The V-shaped ligand bis(N-allylbenzimidazol-2-ylmethyl)benzylamine and its Ag(I) complex: Synthesis, crystal structure, DNA-binding properties and antioxidation. J. Photoch. Photobio. B. 2013, 122, 37– 44.
Kaniskan, N.; Ogretir, C. Investigation of acid–base behaviour of some 2-pyridylbenzimidazoles using semi-empirical methods. J. Mol. Struct. 2002, 584, 45–52.
Sączewski, F.; Dziemidowicz-Borys, E.; Bednarski, P. J. Synthesis, crystal structure and biological activities of copper(II) Complexes with chelating bidentate 2-substituted benzimidazole ligands. Journal of Inorganic Biochemistry. 2006, 100, 1389 –1398.
Rowan, R.; Moran, C.; McCann, M.; Kavanagh, K. Use of Galleria mellonella larvae to evaluate the in vivo anti-fungal activity of [Ag2(mal)(phen)3]. BioMetals. 2009, 22, 461– 467.
McCann, M.; Geraghty, M.; Devereux, M.; O’Shea, D.; Mason., J.; O’Sullivan, L. Insights Into the Mode of Action of the Anti-Candida Activity of 1,10-Phenanthroline and its Metal Chelates. Metal-Based Drugs. 2000, 7, 185–193.
Deegan, C.; Coyle, B.; McCann, M.; Devereux, M.; Egan, D. In vitro anti-tumour effect of 1,10-phenanthroline-5,6-dione (phendione), [Cu(phendione)3](ClO4)2·4H2O and [Ag(phendione)2]ClO4 using human epithelial cell lines. Chem. Biol. Interact. 2006, 164, 115–125.
Cerchiaro, G.; Aquilano, K.; Filomeni, G. Isatin-Schiff base copper(II) complexes and their influence on cellular viability. Journal of Inorganic Biochemistry. 2005, 99, 1433-1440.
Puszyńska-Tuszkanow, M.; Grabowski, T.; Daszkiewicz, M. Silver(I) complexes with hydantoins and allantoin ☆: Synthesis, crystal and molecular structure, cytotoxicity and pharmacokinetics. Journal of Inorganic Biochemistry. 2011, 105, 17–22.

回复此楼